Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin and Ezetimibe Interaction Study
NCT02289430Phase 1Completed
- Sponsor
- NVP Healthcare Co., Ltd.
- Start
- Dec 2014
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, open-label trial in hypercholesterolemia comparing Crestor+Ezetrol, Ezetrol and Crestor (3 arms). Primary endpoint: Area Under Curve. Started Dec 2014; status: completed.
02
Drugs
rosuvastatinezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02289430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02289430.